Back to Authors

Idriss, Munir H.

Mayo Clinic

The University of Texas MD Anderson Cancer Center

Citations 3

Erythematous Plaque Studded With Papules and Pustules in an Immunocompetent Patient
Shahin, Ahmad , Idriss, Munir H., Lehman, Julia S. , Shahin, Ahmad B , Lehman, Julia S

JAMA Dermatology | March 6, 2024 | Volume: 160 | Issue: 5 | Pages: 567

10.1001/jamadermatol.2023.5597 Get It

A male patient was evaluated by the dermatology inpatient consult service after a 5-week history of a skin lesion on the right anterior thigh with intermittent itching and mild tenderness to palpation. What is your diagnosis?
Concomitant hypertrophic lichen planus and squamous cell carcinoma: Clinical features and treatment outcomes
Idriss, Munir H., Barbosa, Naiara S. , Chang, Michael B., Gibson, Lawrence E. , Baum, Christian L. , Vidal, Nahid Y. , Gibson, Lawrence

International Journal of Dermatology | June 29, 2022 | Volume: 61 | Issue: 12 | Pages: 1527-1531

10.1111/ijd.16321 Get It

AbstractBackgroundPatients with hypertrophic lichen planus (HLP) and squamous cell carcinoma (SCC) diagnoses present clinicians with diagnostic and disease management challenges.ObjectiveTo better define the clinical and treatment outcomes of patients with concomitant diagnoses of HLP and SCC.Methods and MaterialsA retrospective review was performed from January 1, 2008, to July 31, 2015, at Mayo Clinic. Patients with a histologic diagnosis of HLP and SCC were included. Patient demographics, associated comorbidities, histopathologic characteristics, treatment, and outcomes were evaluated.ResultsThirty‐three patients were identified; 79% were female, and mostly the lower extremities were involved. Most of the SCCs were well‐differentiated and in situ with the majority treated with destruction or excision. There were no cases of local recurrence, metastasis, or disease‐specific death during the follow‐up period (mean 55.8 months).ConclusionPatients with diagnoses of both HLP and SCC appear to be a distinct population that is predominantly female with lesion predilection for the lower extremities. However, regardless of treatment modality or tumor size, there were no adverse outcomes. An initial trial of more conservative treatment measures with close follow‐up may be reasonable with biopsy of lesions unresponsive to conventional treatment.
Cytokeratin-Derived Amyloid Mimicking Invasive Squamous Cell Carcinoma: Overcoming a Potential Pitfall of Pan-Cytokeratin Immunohistochemistry–Assisted Mohs Micrographic Surgery
Idriss, Munir H., Ahn, Ji Won, Johnson, Emma F. , Vidal, Nahid Y. , Demer, Addison M.

Dermatologic Surgery | May 26, 2022 | Volume: 48 | Issue: 8 | Pages: 887-889

10.1097/dss.0000000000003493 Get It